Correlation Between Ibio and ZyVersa Therapeutics

Can any of the company-specific risk be diversified away by investing in both Ibio and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ibio and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ibio Inc and ZyVersa Therapeutics, you can compare the effects of market volatilities on Ibio and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ibio with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ibio and ZyVersa Therapeutics.

Diversification Opportunities for Ibio and ZyVersa Therapeutics

0.33

Correlation Coefficient

Ibio  ZyVersa Therapeutics

Weak diversification

The 3 months correlation between Ibio and ZyVersa is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Ibio Inc and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and Ibio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ibio Inc are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of Ibio i.e., Ibio and ZyVersa Therapeutics go up and down completely randomly.

Pair Corralation between Ibio and ZyVersa Therapeutics

Given the investment horizon of 90 days Ibio Inc is expected to generate 3.07 times more return on investment than ZyVersa Therapeutics. However, Ibio is 3.07 times more volatile than ZyVersa Therapeutics. It trades about 0.31 of its potential returns per unit of risk. ZyVersa Therapeutics is currently generating about -0.22 per unit of risk. If you would invest  294.00  in Ibio Inc on November 29, 2024 and sell it today you would earn a total of  211.00  from holding Ibio Inc or generate 71.77% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Ibio Inc  vs.  ZyVersa Therapeutics

Ibio Inc

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Ibio Inc are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Ibio displayed solid returns over the last few months and may actually be approaching a breakup point.

ZyVersa Therapeutics

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in ZyVersa Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, ZyVersa Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Ibio and ZyVersa Therapeutics

The main advantage of trading using opposite Ibio and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ibio position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.

The idea behind Ibio Inc and ZyVersa Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.